Cathal Friel
Fondateur chez HVIVO PLC
Fortune : 13 M $ au 30/04/2024
Relations actives
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Brendan Buckley | M | 73 |
Open Orphan DAC
 Open Orphan DAC Packaged SoftwareTechnology Services Open Orphan DAC develops platform for pharmaceutical and biotechnology companies seeking to commercialize their products across Europe. It focuses on building its database of over 500 pharmaceutical companies with orphan drugs either approved or advancing through clinical trials. The company is headquartered in Ballsbridge, Ireland. | 6 ans |
| Rory Nealon | M | 56 |
Amryt Pharma Holdings Ltd.
 Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Amryt Pharma Holdings Ltd. is a pharmaceutical company, which engages in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. Its products include Lomitapide and Metreleptin. The Lomitapide provides homozygous familial hypercholesterolemia (HoFH), and Metreleptin provides treatment for generalized lipodystrophy (GL) and partial lipodystrophy (PL). The company was founded on December 20, 2004 and is headquartered in London, the United Kingdom. | 9 ans |
| Stephen Pinkerton | M | 61 | 7 ans | |
| Martin Gouldstone | M | 57 | 2 ans | |
| Ian O'Connell | M | 37 | 13 ans | |
| Yamin Khan | M | 55 | 3 ans | |
| Ryan Muldoon | M | - |
PrEP Biopharm Ltd.
 PrEP Biopharm Ltd. Pharmaceuticals: MajorHealth Technology PrEP Biopharm Ltd. develops and manufactures biopharmaceutical products. The British company was founded in 2015 by Ryan Muldoon and Bruce A. Malcolm. Ryan Muldoon has been the CEO since 2015. | 9 ans |
| Elaine Sullivan | M | 63 | 4 ans | |
| Reid Tripp | M | - | 10 ans | |
| Bruno Speder | M | - | 4 ans | |
| Luke O'Neill | M | 60 | - | |
| Jeremy Skillington | M | 53 | 3 ans | |
| Andrew Catchpole | M | - | 4 ans | |
| Gerry Sheehan | M | - |
T5 Oil & Gas Ltd.
 T5 Oil & Gas Ltd. Oil & Gas ProductionEnergy Minerals T5 Oil & Gas Ltd. explores oil and gas resources. The firm develops portfolio of conventional oil and gas resources. The company was incorporated by Patrick Joseph Plunkett, Gerry Sheehan, Matthew O'Donoghue, Andrew Guy Windham and Stephen James McTiernan on August 07, 2013 and is headquartered in London, the United Kingdom. | 10 ans |
| Eddie Gibson | M | 50 | 3 ans | |
| Maurice N. Treacy | M | 62 |
Open Orphan DAC
Open Orphan DAC Packaged SoftwareTechnology Services Open Orphan DAC develops platform for pharmaceutical and biotechnology companies seeking to commercialize their products across Europe. It focuses on building its database of over 500 pharmaceutical companies with orphan drugs either approved or advancing through clinical trials. The company is headquartered in Ballsbridge, Ireland. | 5 ans |
| Patrick Joseph Plunkett | M | 74 |
T5 Oil & Gas Ltd.
T5 Oil & Gas Ltd. Oil & Gas ProductionEnergy Minerals T5 Oil & Gas Ltd. explores oil and gas resources. The firm develops portfolio of conventional oil and gas resources. The company was incorporated by Patrick Joseph Plunkett, Gerry Sheehan, Matthew O'Donoghue, Andrew Guy Windham and Stephen James McTiernan on August 07, 2013 and is headquartered in London, the United Kingdom. | 10 ans |
| Mariya Kalinova | F | - | 10 ans | |
| Adam French | M | - | 2 ans | |
| Mohammed Khan | M | 55 | - | |
| Jim Cornelius | M | - |
PrEP Biopharm Ltd.
PrEP Biopharm Ltd. Pharmaceuticals: MajorHealth Technology PrEP Biopharm Ltd. develops and manufactures biopharmaceutical products. The British company was founded in 2015 by Ryan Muldoon and Bruce A. Malcolm. Ryan Muldoon has been the CEO since 2015. | - |
| Carol Dalton | F | - | 3 ans | |
| David English | M | - | 2 ans | |
| Salim Hamir | M | - | - | |
| Christian Klinkenberg | M | - |
Raglan Capital Ltd.
 Raglan Capital Ltd. Investment ManagersFinance Raglan Capital Ltd. is an Irish company that specializes in creating in-house companies for rapid listing on the London Stock Exchange. Raglan Capital aims to create one new company per year and achieve an IPO within three years. The private company has offices in Ireland, the UK, and the US. The company's portfolio includes companies such as Poolbeg Pharma, HVIVO, Amryt Pharma, Fastnet Oil & Gas, and European Green Metals. The company was founded in 2007 by Cathal Martin Friel, who has been the CEO since incorporation. | - |
| Michael Judson | M | - |
T5 Oil & Gas Ltd.
T5 Oil & Gas Ltd. Oil & Gas ProductionEnergy Minerals T5 Oil & Gas Ltd. explores oil and gas resources. The firm develops portfolio of conventional oil and gas resources. The company was incorporated by Patrick Joseph Plunkett, Gerry Sheehan, Matthew O'Donoghue, Andrew Guy Windham and Stephen James McTiernan on August 07, 2013 and is headquartered in London, the United Kingdom. | 7 ans |
| John McEvoy | M | 37 | - | |
| Matthew O'Donoghue | M | - |
T5 Oil & Gas Ltd.
T5 Oil & Gas Ltd. Oil & Gas ProductionEnergy Minerals T5 Oil & Gas Ltd. explores oil and gas resources. The firm develops portfolio of conventional oil and gas resources. The company was incorporated by Patrick Joseph Plunkett, Gerry Sheehan, Matthew O'Donoghue, Andrew Guy Windham and Stephen James McTiernan on August 07, 2013 and is headquartered in London, the United Kingdom. | 10 ans |
| Martin Ewart Johnson | M | - | - | |
| David Allmond | M | 54 | 1 ans | |
| Ross Crockett | M | - | 3 ans | |
| Clive Page | M | 66 |
PrEP Biopharm Ltd.
PrEP Biopharm Ltd. Pharmaceuticals: MajorHealth Technology PrEP Biopharm Ltd. develops and manufactures biopharmaceutical products. The British company was founded in 2015 by Ryan Muldoon and Bruce A. Malcolm. Ryan Muldoon has been the CEO since 2015. | - |
| Laura Maher | F | - | - |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Leo Toole | M | 51 | 3 ans | |
| Ray Stafford | M | 77 |
Amryt Pharma Holdings Ltd.
Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Amryt Pharma Holdings Ltd. is a pharmaceutical company, which engages in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. Its products include Lomitapide and Metreleptin. The Lomitapide provides homozygous familial hypercholesterolemia (HoFH), and Metreleptin provides treatment for generalized lipodystrophy (GL) and partial lipodystrophy (PL). The company was founded on December 20, 2004 and is headquartered in London, the United Kingdom. | 7 ans |
| Joe Wiley | M | 53 |
Amryt Pharma Holdings Ltd.
Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Amryt Pharma Holdings Ltd. is a pharmaceutical company, which engages in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. Its products include Lomitapide and Metreleptin. The Lomitapide provides homozygous familial hypercholesterolemia (HoFH), and Metreleptin provides treatment for generalized lipodystrophy (GL) and partial lipodystrophy (PL). The company was founded on December 20, 2004 and is headquartered in London, the United Kingdom. | 8 ans |
| Aneshkumar Patel | M | 43 | 5 ans | |
| Anthony Culverwell | M | 68 |
Amryt Pharma Holdings Ltd.
Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Amryt Pharma Holdings Ltd. is a pharmaceutical company, which engages in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. Its products include Lomitapide and Metreleptin. The Lomitapide provides homozygous familial hypercholesterolemia (HoFH), and Metreleptin provides treatment for generalized lipodystrophy (GL) and partial lipodystrophy (PL). The company was founded on December 20, 2004 and is headquartered in London, the United Kingdom. | 3 ans |
| David George Kelly | M | 63 | 1 ans | |
| Christian Bernard Milla | M | 61 | 3 ans | |
| Mark Robert Warne | M | 49 | - | |
| Fleur Wood | M | - | 2 ans | |
| Trevor Phillips | M | 63 | - | |
| Patrick Ashe | M | 59 | - | |
| Michael Gerald Meade | M | 64 | 1 ans | |
| Tsz Keung Yeung | M | 59 |
University of Ulster
| 4 ans |
| Markus Ziener | M | 58 |
Amryt Pharma Holdings Ltd.
Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Amryt Pharma Holdings Ltd. is a pharmaceutical company, which engages in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. Its products include Lomitapide and Metreleptin. The Lomitapide provides homozygous familial hypercholesterolemia (HoFH), and Metreleptin provides treatment for generalized lipodystrophy (GL) and partial lipodystrophy (PL). The company was founded on December 20, 2004 and is headquartered in London, the United Kingdom. | 3 ans |
| Antony Barker | M | - |
University of Ulster
| 3 ans |
| Gary Keating | M | 51 |
University of Ulster
| 4 ans |
| Martin Armstrong | M | 58 |
University of Ulster
| 4 ans |
| Michael Ryan | M | 67 | 8 ans | |
| John Murphy | M | - |
University of Ulster
| 4 ans |
| Soo Beng Khor | M | 61 |
University of Ulster
| 4 ans |
| Mark Sumeray | M | 58 |
Amryt Pharma Holdings Ltd.
Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Amryt Pharma Holdings Ltd. is a pharmaceutical company, which engages in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. Its products include Lomitapide and Metreleptin. The Lomitapide provides homozygous familial hypercholesterolemia (HoFH), and Metreleptin provides treatment for generalized lipodystrophy (GL) and partial lipodystrophy (PL). The company was founded on December 20, 2004 and is headquartered in London, the United Kingdom. | 6 ans |
| Chee Hong Leong | M | 58 |
University of Ulster
| 4 ans |
| Yiu Wah Chow | M | 65 |
University of Ulster
| 4 ans |
| John Macrae | M | - |
University of Ulster
| 2 ans |
| Alan Gibson | M | - |
University of Ulster
| 2 ans |
| Malachy McGuinness | M | - |
University of Ulster
| 4 ans |
| Harry Thomas Stratford | M | 54 |
Amryt Pharma Holdings Ltd.
Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Amryt Pharma Holdings Ltd. is a pharmaceutical company, which engages in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. Its products include Lomitapide and Metreleptin. The Lomitapide provides homozygous familial hypercholesterolemia (HoFH), and Metreleptin provides treatment for generalized lipodystrophy (GL) and partial lipodystrophy (PL). The company was founded on December 20, 2004 and is headquartered in London, the United Kingdom. | 3 ans |
| Thomas Gerard Bryce | M | 55 |
University of Ulster
| 4 ans |
| Anthony Francis Richardson | M | 59 | - | |
| Andrew Guy Windham | M | 74 |
T5 Oil & Gas Ltd.
T5 Oil & Gas Ltd. Oil & Gas ProductionEnergy Minerals T5 Oil & Gas Ltd. explores oil and gas resources. The firm develops portfolio of conventional oil and gas resources. The company was incorporated by Patrick Joseph Plunkett, Gerry Sheehan, Matthew O'Donoghue, Andrew Guy Windham and Stephen James McTiernan on August 07, 2013 and is headquartered in London, the United Kingdom. | 4 ans |
| Kieran Hegarty | M | 57 |
University of Ulster
| 1 ans |
| Helen Phillips | M | - |
Amryt Pharma Holdings Ltd.
Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Amryt Pharma Holdings Ltd. is a pharmaceutical company, which engages in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. Its products include Lomitapide and Metreleptin. The Lomitapide provides homozygous familial hypercholesterolemia (HoFH), and Metreleptin provides treatment for generalized lipodystrophy (GL) and partial lipodystrophy (PL). The company was founded on December 20, 2004 and is headquartered in London, the United Kingdom. | - |
Statistiques
| Pays | Relations | % du total |
|---|---|---|
| Royaume-Uni | 64 | 98,46% |
| Irlande | 3 | 4,62% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Cathal Friel
- Réseau Personnel
